Abbott Laboratories

NYSE: ABT
$117.73
+$0.47 (+0.4%)
Closing Price on November 22, 2024

ABT Articles

The top analyst upgrades, downgrades and other research calls from Thursday include Adobe, Allergan, American Express, Baker Hughes, Nike, Northern Dynasty Minerals, Sprint and Wayfair.
The top analyst upgrades, downgrades and other research calls from Friday include Albermarle, Anadarko, Costco, Cree, Kraft Heinz, Netflix, Valero and Walt Disney.
The top analyst upgrades, downgrades and other research calls from Thursday include Abbott Laboratories, Baxter International, Cisco Systems, National Oilwell Varco, Nucor, Procter & Gamble and...
Deutsche Bank raised price targets on two red-hot tech stocks that report earnings this week and another tech and a top health care name that already reported stellar results.
These four large cap leaders that have a value profile look attractive now for investors trying to play it a little safer for the second half of 2017.
The top analyst upgrades, downgrades and other research calls from Wednesday include Abbott Laboratories, Advanced Micro Devices, Chesapeake Energy, Intel, PayPal, Target, Weatherford International...
With interest rates once again dropping as the geopolitical worries ratchet up, investors are concerned about owning good stocks and receiving dependable dividends. One place that looks very good now...
These five Dividend Aristocrats, if purchased soon, should reward investors with a payout early next quarter.
The top analyst upgrades, downgrades and initiations seen on Tuesday include Mobileye, Occidental Petroleum, Oracle, Walt Disney, Wal-Mart.
Wednesday’s top analyst upgrades, downgrades and initiations include Abbott Labs, General Dynamics, Nexstar Media, Owens Corning, Palo Alto Networks and Salesforce.com.
With inflation, higher interest rates and a host of potential volatility events around the corner, it makes sense now to play it safe. The place to look now is for growth companies that are paying a...
These five stocks pay solid distributions, are not trading at all-time highs and are rated Buy at Merrill Lynch. They make good sense should a big sell-off hit the market.
The pricier the market gets, the more it makes sense to stay with industry leaders, especially those that have paid and raised their dividends consistently.
Bank of America, Chesapeake Energy and General Electric all saw double-digit percentage drops in their short interest in the waning days of 2016.
For more conservative investors looking for growth and income, these stocks make good sense for 2017 and beyond.